Vor Biopharma’s Promising Clinical Trials and Strategic Planning Earn a Buy Rating
Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Vor Biopharma (VOR – Research Report). The associated price ...
manilatimes11 小时
EnteroBiotix Announces Positive Ph1b Clinical Results of EBX-102 in Liver Cirrhosis
Glasgow, Scotland - 11 November 2024. EnteroBiotix Limited ('EnteroBiotix' or the 'Company'), a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome ...